Chemical Structure |
2048-bit vector |
ECFP4 (Morgan) fingerprints representing chemical structures |
Distinctive patterns of chemical bonding and arrangement |
52
|
Physicochemical properties (Mordred Descriptors) |
1038 2-D descriptors |
Properties such as lipophilicity, solubility, molecular weight, ionizing potential, etc. |
Properties that are associated with negative impacts on ion channels in the heart |
41
|
MOA dataset |
264 binary encoded MOAs + 551 known targets |
Annotations for mechanism of action and known targets based on knowledge. |
Mechanism of action for drugs that inhibit certain ion channels |
29
|
CellScape Target Prediction dataset |
1893 predictions for 817 unique targets and concentration combinations (0.1, 1, 10, and 100uM) |
Predicted protein target for inhibition/antagonism; does not consider the functionality; prediction is based on chemical structure; updated algorithm from PIDGINv443
|
Understanding how a drug interacts with various biological targets (not just its primary target) can provide insights into potential off-target effects |
34,43
|
Cell Painting |
1783 features |
Morphological changes in U2OS cells by a chemical perturbation, using a 5-channel fluorescence microscopy assay |
Morphological changes in cells that reflect basic biological processes |
24,53
|
Gene Expression |
978 features |
Transcriptomic changes in response to chemicals using the L1000 assay |
Upregulation or downregulation of genes associated with cardiac stress, apoptosis in cardiac cells, or ion channel function |
19,25
|
Gene Ontology |
4438 annotations |
Gene Ontology manual annotations based on collective knowledge |
Understanding the biological processes, cellular components, and molecular functions affected, e.g., related to cardiac function, cardiac muscle tissue development, or ion homeostasis |
19,26
|
Cmax |
2 features |
The maximum total and unbound concentration of a drug in plasma |
High Cmax would indicate a high risk of cardiotoxicity |
30
|